WallStSmart

Avepoint Inc (AVPT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Avepoint Inc generates 62% more annual revenue ($419.50M vs $258.90M). AVPT leads profitability with a 8.3% profit margin vs -15.5%. AVPT earns a higher WallStSmart Score of 50/100 (C-).

AVPT

Buy

50

out of 100

Grade: C-

Growth: 9.3Profit: 6.0Value: 5.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVPTUndervalued (+32.1%)

Margin of Safety

+32.1%

Fair Value

$15.55

Current Price

$9.92

$5.63 discount

UndervaluedFair: $15.55Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVPT2 strengths · Avg: 9.0/10
EPS GrowthGrowth
500.0%10/10

Earnings expanding 500.0% YoY

Revenue GrowthGrowth
28.6%8/10

Revenue surging 28.6% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

AVPT1 concerns · Avg: 2.0/10
P/E RatioValuation
66.1x2/10

Premium valuation, high expectations priced in

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : AVPT

The strongest argument for AVPT centers on EPS Growth, Revenue Growth. Revenue growth of 28.6% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : AVPT

The primary concerns for AVPT are P/E Ratio. A P/E of 66.1x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

AVPT profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AVPT scores higher overall (50/100 vs 41/100) and 28.6% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Avepoint Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

AvePoint Inc. (AVPT) is a premier provider of sophisticated data management solutions tailored for Microsoft 365 and various collaboration platforms, with a strong emphasis on governance, compliance, and data protection. As organizations navigate their digital transformation journeys, AvePoint delivers a comprehensive suite of products that enhance operational efficiency while safeguarding critical data assets. The company's commitment to security and innovation positions it strategically to capture the escalating demand for resilient data management solutions in a rapidly evolving cloud environment. Leveraging a strong customer-centric approach, AvePoint is poised for sustained growth in a digital-first landscape, making it an attractive prospect for institutional investors.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?